Diphenyl diselenide protects rat hippocampal slices submitted to oxygen-glucose deprivation and diminishes inducible nitric oxide synthase immunocontent

被引:79
作者
Ghisleni, G
Porciúncula, LO
Cimarostia, H
Rocha, JBT
Salbego, CG
Souza, DO
机构
[1] Univ Fed Rio Grande do Sul, Dept Bioquim, ICBS, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Santa Maria, CCNE, Dept Quim, BR-97119900 Santa Maria, RS, Brazil
关键词
brain ischemia; oxygen-glucose deprivation; selenium; neuroprotection; diphenyl diselenide; ebselen;
D O I
10.1016/S0006-8993(03)03193-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Diphenyl diselenide (PhSe)(2) is an organic selenium compound that has been little studied. In this study we investigated the effects of (PhSe)(2) (0.1-3 muM) in a classical model of in vitro brain ischemia, which consists of exposing rat hippocampal slices to oxygen-glucose deprivation (OGD). Hippocampal slices were exposed for 60 min to OGD and the cellular viability (performed by MTT assay) as well as the immunocontent of nitric oxide synthase inducible (iNOS) were evaluated after 180 min of a recovery period. OGD decreased cellular viability by 50% and increased more than twice the immunocontent of iNOS of hippocampal slices. (PhSe)(2) (1 and 3 muM) added during OGD and the recovery period abolished both effects. These results demonstrate for the first time the neuroprotective effects of (PhSe)(2). Although the selenium analog-ebselen-has been widely used in ischemia models, our results suggest that other selenoorganic compounds could be investigated as pharmacological tools against brain disorders. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:196 / 199
页数:4
相关论文
共 31 条
[1]   NITRIC-OXIDE - A PHYSIOLOGICAL MESSENGER MOLECULE [J].
BREDT, DS ;
SNYDER, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :175-195
[2]   Protective effect of N-(3-(aminomethyl benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation [J].
Cárdenas, A ;
De Alba, J ;
Moro, MA ;
Leza, JC ;
Lorenzo, P ;
Lizasoain, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (2-3) :161-165
[3]   Use of brain slices in the study of pathogenic role of inducible nitric oxide synthase in cerebral ischemia-reperfusion [J].
De Alba, J ;
Cárdenas, A ;
Moro, MA ;
Leza, JC ;
Lorenzo, P ;
Lizasoain, I .
GENERAL PHARMACOLOGY, 1999, 32 (05) :577-581
[4]   Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells [J].
deMello, MAR ;
Flodstrom, M ;
Eizirik, DL .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (11) :1703-1709
[5]   EXPRESSION OF THE INDUCIBLE FORM OF NITRIC-OXIDE SYNTHASE BY REACTIVE ASTROCYTES AFTER TRANSIENT GLOBAL-ISCHEMIA [J].
ENDOH, M ;
MAIESE, K ;
WAGNER, J .
BRAIN RESEARCH, 1994, 651 (1-2) :92-100
[6]  
Fern R, 2001, Prog Brain Res, V132, P405
[7]   NITRIC-OXIDE - PATHOPHYSIOLOGICAL MECHANISMS [J].
GROSS, SS ;
WOLIN, MS .
ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 :737-769
[8]   The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site [J].
Herin, GA ;
Du, S ;
Aizenman, E .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (06) :1307-1314
[9]   INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE AMELIORATES CEREBRAL ISCHEMIC DAMAGE [J].
IADECOLA, C ;
ZHANG, FY ;
XU, XH .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1995, 268 (01) :R286-R292
[10]   Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice [J].
Jacques-Silva, MC ;
Nogueira, CW ;
Broch, LC ;
Flores, EMM ;
Rocha, JBT .
PHARMACOLOGY & TOXICOLOGY, 2001, 88 (03) :119-125